Young-Woo KIM Chair IARC Scientific Council Goyang, Korea (Republic of)

Young-Woo Kim, MD, PhD. FRCS
Chair, Scientific Council, IARC.
Former Director, Research institute, National Cancer Center,Goyang, Korea.
Professor, Department of Cancer Control and Population Health. National cancer Center Graduate School of Cancer Science and Policy & Center for Gastric Cancer, National Cancer Center,Goyang,Korea.

Professor Young-Woo Kim was born in Korea. He is a distinguished surgical oncologist and academic leader specializing in gastric cancer research and treatment. He earned his MD (1988), MSc (1992), and PhD (1998) from Seoul National University College of Medicine. After serving as faculty at Ewha Womans University, Dr. Kim joined the National Cancer Center (NCC), Korea, where he has held key leadership positions including Chief Scientist of the Gastric Cancer Branch, Head of the Center for Gastric Cancer, and Chief of the Department of Surgery. From 2021 to 2025, he served as Director of the NCC Research Institute.

He is currently Professor in the Department of Cancer Control and Population Health/Public Health & AI at the NCC Graduate School of Cancer Science and Policy. Internationally, he currently serves as Chair of the IARC Scientific Council and domestically, served as Chairman of Korea’s National Cancer Control Planning Board.

He is a principal investigator in multiple landmark clinical and translational studies—including the FAIRY, COACT 1001, ADDICT and K-PRECISION trials and has authored over 380 scientific publications and contributed to major surgical oncology textbooks. His extensive editorial service spans leading journals such as Gastric Cancer, World Journal of Surgery, Surgical Endoscopy and European Journal of Surgical Oncology.

Dr. Kim’s contributions to oncology and surgical innovation have been recognized with numerous honors, including the Civil Merit Medal from the President of Korea (2023), the Doosan Yonkang Academic Award (2017), and international distinctions such as the Karl Storz EAES Award. He continues to advance precision surgery and AI-driven cancer care while mentoring the next generation of oncologic surgeons and researchers.